Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1444 EUR | +1.55% | -3.73% | -37.22% |
Jun. 27 | TME Pharma N.V. Appoints Lee Schalop as Member of the Supervisory Board | CI |
Jun. 19 | TME Pharma: in the red, a broker cuts its target | CF |
Chart calendar TME Pharma N.V.
Upcoming events on TME Pharma N.V.
Past events on TME Pharma N.V.
2024-06-27 07:30 am | Annual General Meeting |
2024-04-25 12:00 pm | Q4 2023 Earnings Release |
2024-03-25 | Glioblastoma Development Summit |
2024-03-17 | Bio Europe Spring Conference |
2023-11-17 10:30 pm | Society for Neuro Oncology Meeting |
2023-10-27 12:00 pm | Q2 2023 Earnings Release |
2023-10-21 05:15 am | European Society for Medical Oncology Congress |
2023-06-29 07:30 am | Annual General Meeting |
2023-06-03 02:15 pm | American Society of Clinical Oncology Conference - abstract #2048 |
2023-06-01 | American Society of Clinical Oncology Conference |
2023-04-24 12:00 pm | Q4 2022 Earnings Release |
2023-01-30 07:30 am | Extraordinary Shareholders Meeting |
2022-11-22 12:00 pm | Investor Meeting - Key Opinion Leader |
2022-11-18 07:30 pm | Society for Neuro-Oncology Meeting - Abstract No: CTNI-67 |
2022-10-26 01:00 pm | Interim 2022 Earnings Release |
2022-10-23 | BIO Europe Conference |
2022-09-20 | Sachs Associates Biotech in Europe Forum |
2022-09-08 | ESMO Congress Conference |
2022-06-29 08:00 am | Annual General Meeting |
2022-06-10 08:00 am | Investor Meeting - Key Opinion Leader |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 6,60 - | 0,03 0,10 -66% |
EBITDA Million EUR | Released Forecast Spread | -3,90 -4,95 21.19% | 0,00 | -13,2 -5,20 -153.87% | -11,9 -16,3 26.77% |
EBIT Million EUR | Released Forecast Spread | -3,95 -5,05 21.82% | 0,00 | -13,3 -5,30 -150.32% | -12,0 -16,3 26.2% |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
Net income Million EUR | Released Forecast Spread | -0,86 -5,50 84.35% | -10,4 | 0,00 0,00 - | 0,00 0,00 - |
EPS EUR | Released Forecast Spread | 0,00 0,00 - | -32,0 | 0,00 0,00 - | 0,00 0,00 - |
Announcement Date | 22/04/20 | 28/04/21 | 22/04/22 | 24/04/23 |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for TME Pharma N.V.
2024-06-07 02:57 am | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- ALTME Stock
- Calendar TME Pharma N.V.